Literature DB >> 12072502

Herpes simplex virus type 1 origins of DNA replication play no role in the regulation of flanking promoters.

Bretton C Summers1, David A Leib.   

Abstract

Herpes simplex virus (HSV) exhibits altered gene regulation in neuronal compared to nonneuronal tissues. It has been hypothesized that initiation of DNA synthesis at the viral origins of replication (oriS and oriL) is a critical step in the upregulation of transcriptional activity of flanking divergent promoters, thereby increasing productive gene expression in neurons. Notably, oriS is flanked by the immediate-early (IE) ICP4 and ICP22/47 promoters, and oriL is flanked by the early (E) UL29 and UL30 promoters. To test this hypothesis further, a series of constructs were generated in which these promoters were placed upstream of luciferase genes. In addition, DNA replication origins were deleted in the context of these promoter constructs. All cassettes were recombined into the viral genome of HSV type 1 strain KOS at a site distal to its native origins. Recombinant reporter expression was monitored in vitro and in vivo to determine the role of viral origins of DNA replication in the regulation of their flanking promoters. Reporter gene expression was unaffected by the presence or absence of oriS or oriL, with the exception of a twofold increase in ICP22/47 promoter activity in the absence of oriS. DNA synthesis inhibitors resulted in a decrease of both IE- and E-promoter activity in primary cells but not continuous cell cultures. Reporter activity was readily assayed in vivo during acute infection and reactivation from latency and was also sensitive to DNA synthesis inhibitors. In all assays, reporter gene expression was unaffected by the presence or absence of either oriS or oriL. These data support the requirement of DNA synthesis for full viral gene expression in vivo but suggest that the origin elements play no role in the regulation of their flanking promoters.

Entities:  

Mesh:

Year:  2002        PMID: 12072502      PMCID: PMC136320          DOI: 10.1128/jvi.76.14.7020-7029.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

Review 1.  Repression of viral transcription during herpes simplex virus latency.

Authors:  C M Preston
Journal:  J Gen Virol       Date:  2000-01       Impact factor: 3.891

2.  Regulation of herpesvirus macromolecular synthesis: evidence for multilevel regulation of herpes simplex 1 RNA and protein synthesis.

Authors:  B Roizman; M Kozak; R W Honess; G Hayward
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

3.  Regulation of herpesvirus macromolecular synthesis: sequential transition of polypeptide synthesis requires functional viral polypeptides.

Authors:  R W Honess; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

4.  Cloning, sequencing, and functional analysis of oriL, a herpes simplex virus type 1 origin of DNA synthesis.

Authors:  S K Weller; A Spadaro; J E Schaffer; A W Murray; A M Maxam; P A Schaffer
Journal:  Mol Cell Biol       Date:  1985-05       Impact factor: 4.272

5.  Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins.

Authors:  R W Honess; B Roizman
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

6.  Cell type-specific markers for human glial and neuronal cells in culture.

Authors:  P G Kennedy; R P Lisak; M C Raff
Journal:  Lab Invest       Date:  1980-10       Impact factor: 5.662

7.  The transcriptional activation domain of VP16 is required for efficient infection and establishment of latency by HSV-1 in the murine peripheral and central nervous systems.

Authors:  R Tal-Singer; R Pichyangkura; E Chung; T M Lasner; B P Randazzo; J Q Trojanowski; N W Fraser; S J Triezenberg
Journal:  Virology       Date:  1999-06-20       Impact factor: 3.616

8.  ICP0, ICP4, or VP16 expressed from adenovirus vectors induces reactivation of latent herpes simplex virus type 1 in primary cultures of latently infected trigeminal ganglion cells.

Authors:  W P Halford; C D Kemp; J A Isler; D J Davido; P A Schaffer
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

9.  Accumulation of herpes simplex virus type 1 RNAs of different kinetic classes in the cytoplasm of infected cells.

Authors:  E Harris-Hamilton; S L Bachenheimer
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

10.  Replication origins and a sequence involved in coordinate induction of the immediate-early gene family are conserved in an intergenic region of herpes simplex virus.

Authors:  J L Whitton; J B Clements
Journal:  Nucleic Acids Res       Date:  1984-02-24       Impact factor: 16.971

View more
  24 in total

1.  A sequence within the varicella-zoster virus (VZV) OriS is a negative regulator of DNA replication and is bound by a protein complex containing the VZV ORF29 protein.

Authors:  Mohamed I Khalil; Ann Arvin; Jeremy Jones; William T Ruyechan
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

2.  The virion host shutoff protein of herpes simplex virus type 1 has RNA degradation activity in primary neurons.

Authors:  Stephanie S Strand; Tambryn K Vanheyningen; David A Leib
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

3.  Role of the DNA Sensor STING in Protection from Lethal Infection following Corneal and Intracerebral Challenge with Herpes Simplex Virus 1.

Authors:  Zachary M Parker; Aisling A Murphy; David A Leib
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

4.  Herpes simplex virus 1 immediate-early and early gene expression during reactivation from latency under conditions that prevent infectious virus production.

Authors:  Jean M Pesola; Jia Zhu; David M Knipe; Donald M Coen
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  Herpes simplex virus DNA synthesis is not a decisive regulatory event in the initiation of lytic viral protein expression in neurons in vivo during primary infection or reactivation from latency.

Authors:  N M Sawtell; R L Thompson; R L Haas
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

6.  Noninvasive bioluminescence imaging of herpes simplex virus type 1 infection and therapy in living mice.

Authors:  Gary D Luker; J Patrick Bardill; Julie L Prior; Christina M Pica; David Piwnica-Worms; David A Leib
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

7.  Site-directed mutagenesis of large DNA palindromes: construction and in vitro characterization of herpes simplex virus type 1 mutants containing point mutations that eliminate the oriL or oriS initiation function.

Authors:  John W Balliet; Jonathan C Min; Mark S Cabatingan; Priscilla A Schaffer
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

8.  The RNA Exosome Syncs IAV-RNAPII Transcription to Promote Viral Ribogenesis and Infectivity.

Authors:  Alexander Rialdi; Judd Hultquist; David Jimenez-Morales; Zuleyma Peralta; Laura Campisi; Romain Fenouil; Natasha Moshkina; Zhen Zhen Wang; Brice Laffleur; Robyn M Kaake; Michael J McGregor; Kelsey Haas; Evangelos Pefanis; Randy A Albrecht; Lars Pache; Sumit Chanda; Joanna Jen; Jordi Ochando; Minji Byun; Uttiya Basu; Adolfo García-Sastre; Nevan Krogan; Harm van Bakel; Ivan Marazzi
Journal:  Cell       Date:  2017-05-04       Impact factor: 41.582

9.  The STING agonist 5,6-dimethylxanthenone-4-acetic acid (DMXAA) stimulates an antiviral state and protects mice against herpes simplex virus-induced neurological disease.

Authors:  Stacey Cerón; Brian J North; Sean A Taylor; David A Leib
Journal:  Virology       Date:  2019-01-06       Impact factor: 3.616

10.  Bioluminescence imaging reveals systemic dissemination of herpes simplex virus type 1 in the absence of interferon receptors.

Authors:  Gary D Luker; Julie L Prior; Jiling Song; Christina M Pica; David A Leib
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.